Rs 1,900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You

Options Event and Cash Market Price Action

The most active call options on Sun Pharmaceutical Industries Ltd on 09 Jul 2026 were concentrated at the Rs 1,900 strike expiring on 28 Jul 2026. A total of 3,987 contracts exchanged hands at this strike, generating a turnover of approximately ₹63.06 crores. This activity was complemented by significant volumes at the Rs 1,920 and Rs 1,940 strikes, with 5,282 and 5,078 contracts traded respectively. The underlying stock closed at Rs 1,934.0, marking a 2.70% gain on the day and hitting a new 52-week high of Rs 1,933.6. This price action confirms the options market’s bullish undertone — is this a momentum play worth joining or has the easy move already happened?

Strike Price and Moneyness Analysis

The Rs 1,900 strike calls are slightly in-the-money (ITM) given the underlying’s close at Rs 1,934.0. This positioning indicates a degree of conviction beyond mere speculation, as ITM calls typically reflect hedging or a strong directional bet with intrinsic value. Meanwhile, the Rs 1,920 strike is effectively at-the-money (ATM), positioned just below the current price, signalling an immediate directional wager sensitive to short-term price fluctuations. The Rs 1,940 strike calls, being out-of-the-money (OTM), represent a more speculative upside bet, anticipating further gains beyond the current price level. The spread of activity across these strikes suggests layered positioning, combining near-term directional bets with speculative upside exposure — what does the strike price selection reveal about market sentiment?

Open Interest and Contracts Analysis

Open interest (OI) at the Rs 1,900 strike stands at 5,513 contracts, higher than the day’s traded volume of 3,987 contracts. This OI level indicates a well-established position base, with the contracts-to-OI ratio at approximately 0.72, suggesting a mix of fresh and existing activity. At the Rs 1,920 strike, OI is 3,434 against 5,282 contracts traded, pushing the ratio above 1.5, which points to predominantly fresh positioning. The Rs 1,940 strike shows a lower OI of 1,933 versus 5,078 contracts traded, yielding a ratio of about 2.6 — a clear sign of new speculative bets entering the market. This distribution highlights that while some positions are being rolled or adjusted at ITM strikes, the bulk of the activity at ATM and OTM strikes is fresh money entering the call options market — is this surge in fresh positioning signalling sustained bullishness or short-term speculation?

Cash Market Context: Momentum and Moving Averages

Sun Pharmaceutical Industries Ltd has demonstrated robust momentum, outperforming its sector by 1.08% on the day and rallying after two consecutive days of decline. The stock trades comfortably above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, underscoring a sustained uptrend. The recent new 52-week high at Rs 1,933.6 aligns closely with the strike prices attracting call activity, reinforcing the notion that the options market is reflecting the cash market’s positive technical signals — buy, sell, or hold Sun Pharmaceutical Industries Ltd given this technical alignment?

Delivery Volume and Market Participation

Delivery volumes on 08 Jul 2026 surged to 15.71 lakh shares, a 67.14% increase over the 5-day average, signalling strong investor participation in the cash market. This rise in delivery volume confirms that the recent price gains are supported by genuine buying interest rather than speculative trading alone. The liquidity profile remains robust, with the stock’s average traded value supporting sizeable trade sizes of around ₹7.73 crores. The convergence of rising delivery volumes and heavy call option activity suggests that the derivatives market is not acting in isolation but is in sync with cash market fundamentals — is this alignment a sign of durable strength or a temporary rally?

Key Data at a Glance

Interpreting the Options and Cash Market Signals

The concentration of call contracts at the Rs 1,900 strike, slightly ITM, combined with the underlying price hovering just above this level, points to a confident directional stance with some intrinsic value protection. The significant fresh positioning at ATM and OTM strikes, especially the Rs 1,920 and Rs 1,940 strikes, indicates layered bullish bets with varying risk appetites. The stock’s strong technical backdrop, trading above all major moving averages and hitting a new 52-week high, corroborates the options market’s optimism. Furthermore, the surge in delivery volumes confirms that the cash market is participating actively, lending credibility to the derivatives activity rather than signalling a divergence — how sustainable is this combined momentum across cash and options markets?

Conclusion: What the Call Activity and Price Action Collectively Indicate

The heavy call option activity at strikes clustered around the current price level, combined with a strong underlying price rally and rising delivery volumes, paints a picture of confident directional positioning in Sun Pharmaceutical Industries Ltd. The mixture of ITM, ATM, and OTM call contracts traded suggests a blend of hedging and speculative bets, with fresh money entering the market as evidenced by the contracts-to-OI ratios. The stock’s technical strength, trading above all key moving averages and setting new highs, aligns with this options market optimism. However, the proximity of the expiry on 28 Jul 2026 adds a time-sensitive element to these positions, emphasising short-term conviction rather than long-term bets — should investors weigh this short-term options momentum against broader market conditions?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →